Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium changes in megaloblastic anaemia.

R Hesp, I Chanarin, C E Tait

    Clinical Science and Molecular Medicine
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Epithelial Surfaces and Folate Metabolism.

    Journal of the Royal College of Physicians of London·2019
    Same author

    Normal formiminoglutamic acid excreton in megaloblastic anaemia in pregnancy studies on histidine metabolism in pregnancy.

    Lancet (London, England)·2014
    Same author

    Chronic toxicity in epileptic patients receiving single-drug treatment.

    British medical journal (Clinical research ed.)·2010
    Same author

    Historical review: a history of pernicious anaemia.

    British journal of haematology·2000
    Same author

    Causes of impaired fetal growth.

    Journal of the Royal Society of Medicine·2000
    Same author

    Diagnosis of cobalamin deficiency: the old and the new.

    British journal of haematology·1997

    Megaloblastic anemia treatment initially lowers serum potassium, but total-body potassium increases during recovery. This study tracked potassium levels in patients undergoing therapy for this blood disorder.

    Area of Science:

    • Hematology
    • Clinical Biochemistry
    • Nutritional Science

    Background:

    • Megaloblastic anemia is a condition characterized by large, immature red blood cells.
    • Potassium balance is crucial for overall health, particularly during cellular proliferation and recovery phases.
    • Understanding potassium dynamics in megaloblastic anemia is important for effective patient management.

    Purpose of the Study:

    • To investigate serial changes in serum potassium and total-body potassium during therapy for megaloblastic anemia.
    • To correlate these potassium changes with packed cell volume and other physiological markers.
    • To elucidate the factors contributing to alterations in total-body potassium during recovery.

    Main Methods:

    • Serial measurements of serum potassium and total-body potassium were performed on 18 patients.

    Related Experiment Videos

  • Measurements were taken before therapy initiation and throughout the recovery period.
  • Packed cell volume was assessed to categorize patient severity.

    • Main Results:

    • Patients with initial packed cell volume <25% showed a mean serum potassium decrease of 0.4 mmol/L within 2.5 days of therapy.
    • A significant increase in serum potassium was observed during the recovery phase.
    • Total-body potassium increased significantly, attributable to rises in erythrocyte mass, erythrocyte potassium concentration, and lean body mass.

    Conclusions:

    • Initial therapy for megaloblastic anemia can lead to a transient hypokalemic state.
    • Total-body potassium increases during recovery, influenced by expanding red blood cell mass and lean body mass.
    • Monitoring potassium levels is essential during megaloblastic anemia treatment, especially in severely anemic patients.